So Entresto is ready to be rolled out in the US with a price tag of around $4,500 a year. Novartis has hinted at an outcomes-based pricing plan but there are no details of any scheme or how it ...

Novartis has responded to the inclusion of its heart failure blockbuster Entresto on the list of the first 10 drugs that will be subject to Medicare pricing negotiations, claiming that the move ...

In the past two years we have observed 4 patients with manifestations of deranged function of the central nervous system in whom hyponatremia appeared to be related to an abnormal secretion of ...

Hyponatremia commonly occurs in patients with aneurysmal subarachnoid hemorrhage. Two mechanisms have been proposed as causes: syndrome of inappropriate anti-diuretic hormone and cerebral salt ...

Background Exercise-Associated Hyponatremia (EAH) is a potentially fatal condition during endurance exercise (Petzold et al, 2007). Excessive fluid intake over and above normal fluid losses is the ...

Hyponatremia (defined as serum sodium concentration <135 mmol/l) represents a previously unrecognized cause of osteoporosis, say researchers of a new study published in the Journal of Bone and ...

A federal court in Delaware has reportedly ruled against Novartis (NYSE:NVS) in its quest to block the launch of a generic ...